RxDoctor Payments Data

Gregory Bashian, MD

Clinical Cardiac Electrophysiology · Nashville, TNNPI 1487854311

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $282,859 of the $360,889 with a category attached, or 78.4%. Sanofi-aventis U.S. LLC accounts for 67.2% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $117,163 and has fallen 93.0% since, to $8,230 in 2025. Among clinical cardiac electrophysiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$360,889in general payments, 2019–2025

Across 611 payments — averaging $590.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$242K
  • Abbott$46K
  • Pfizer$35K
  • E.r. Squibb & Sons, L.L.C.$23K
  • Medtronic$6K
  • Boston Scientific$5K
  • plus $3K from 26 others
$174,895in research payments, 2019–2025

Across 101 payments — averaging $1731.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$106K
  • Boston Scientific$39K
  • Medtronic$15K
  • Cardiva Medical, Inc.$15K

What the payments were for

  • Consulting fees$54,15915%
  • Speaking & faculty fees$282,85978%
  • Travel & lodging$8,4682%
  • Food & beverage$15,3504%
  • Education$540%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$360,889 in reported general payments places this provider in the 95th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.

See all clinical cardiac electrophysiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$457,740
Medicare patients
794
Services billed
6,382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban494$558,809
XareltoRivaroxaban81$96,376
MultaqDronedarone Hcl63$81,991
Metoprolol Succinate246$5,127
Amiodarone Hcl133$3,743
Diltiazem 24hr Er (Cd)Diltiazem Hcl79$3,116
Diltiazem 12hr ErDiltiazem Hcl21$3,056
Dabigatran EtexilateDabigatran Etexilate Mesylate12$2,638
Mexiletine Hcl13$2,145
SotalolSotalol Hcl85$1,982
Diltiazem 24hr Er (La)Diltiazem Hcl16$1,083
Verapamil ErVerapamil Hcl17$660
Dilt-XrDiltiazem Hcl19$634
Cartia XtDiltiazem Hcl13$524
Diltiazem 24hr Er (Xr)Diltiazem Hcl15$474

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$35,369$558,809494 claims
Johnson & JohnsonXarelto$31$96,37681 claims
Sanofi-aventis U.S. LLCMultaq$242,370$81,99163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.

Other clinical cardiac electrophysiology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →